As many chemotherapeutics target cancer cells by inducing apoptosis, this novel observation may be of particular relevance to clinical findings that show a functional relationship between high TIMP-1, resistance to apoptosis, and tumor drug resistance [12]–[15]. This evidence concerns the gene TIMP1 and neoplasm.